Employed: 2023
Born: 1973
Education: MSc, Swedish Royal Institute of Technology
Background: 20+ years of leading roles in life science industry. Chairman of the Board of Senzime 2016-2023. CEO and co-founder of Acacia Designs BV (acquired by Senzime in 2016), CEO and co-founder of Coala Life AB (publ.), and CEO of Stille AB (publ.).
Other assignments: Chairman of Acarix AB (publ) and Board Member of Paindrainer AB. Partner at Southbloom SBCF and CEO and deputy board member of Longmeadow Farm AB.
Shareholding in Senzime: Philip Siberg owns a total of 705,542 shares personally and via associated companies, as well as 75,000 stock options in program 2023/2026.
Employed: 2022
Born: 1970
Education: BSc in Business Administration and Economics.
Background: Over 13 years of experience from medium-sized and big listed US companies within life science. Experience includes financial reporting, internal financial management and business development, change management and financial processes solutions as well as business controlling and analytics. Previous positions include roles as Nordic Finance Manager, Finance Business Partner and Senior Business Analyst.
Other assignments: –
Own and related parties’ shareholding in Senzime: 24,919 shares. 100,000 stock options in program 2022/2026 and 75,000 stock options in program 2023/2027.
Employed: 2016
Born: 1967
Education: MSc engineering
Background: Broad experience in R&D. Senior positions in companies within life science and technical consulting. Previous positions include research and development, manufacturing, service, and technical sales in a global environment.
Other assignments: Board member of Klaria Pharma Holding AB and deputy board member of MD Biomedical AB.
Own and related parties’ shareholding in Senzime: 16,000 shares. 80,000 stock options in program 2020/2024, and 75 000 stock options in program 2023/2027.
Employed: 2019
Born: 1962
Education: Brian Tracy Business School and Lean Six Sigma Green Belt
Background: 30 years’ experience in working in global listed medical technology companies with sales, marketing, technical services, and product development with leading positions such as VP and GM in EMEA, Asia and Latin America. Recent position was Head of Strategic Programs and Projects and Head of Development and Management of Medical Care Technology at Karolinska Hospital, Stockholm.
Other assignments: –
Own and related parties’ shareholding in Senzime: 80,000 stock options in program 2020/2024, 80,000 stock options in program 2022/2026, and 75, 000 stock options in program 2023/2027.
Employed: 2020
Born: 1980
Education: Bachelor of Health Sciences in Respiratory Care, University of Missouri.
Background: Registered Respiratory Care Practitioner. 15+ years of US clinical sales and leadership roles with focus on anaesthesia and respiratory solutions.
Other assignments: –
Employed: 2018
Born: 1975
Education: Bachelor of Science in Mechanical Engineering
Background: 20 years of experience working with medical technology products, such as product development and production development. Broad experience in the field of quality, regulatory and sustainability.
Other assignments: –
Own and related parties’ shareholding in Senzime: 1,561 shares. 70,000 stock options in program 2020/2024, 40,000 stock options in program 2022/2026, and 75,000 stock options in program 2023/2027.
Employed: 2020
Born: 1970
Education: Bachelor of Science in Mechanical Engineering
Background: 30 years’ experience in working with medical device with production, supply chain and development. Previous position was as COO at Coala Life and before that senior positions at for example Cavidi, St Jude Medical and Radi Medical systems AB.
Other assignments: –
Own and related parties’ shareholding in Senzime: 65,000 stock options in program 2020/2024, 50,000 stock options in program 2022/2026, and 75, 000 stock options in program 2023/2027.
Employed: 2024
Born: 1988
Education: Bachelor of Business Administration (BBA), Marketing Southern Methodist University, Dallas, TX USA and Master of Business Administration (MBA) University of Colorado, Denver, CO, USA
Background: 15+ years of Senior Marketing roles within the patient monitoring division of Medtronic, US, and Cochlear Americas, a multi-billion dollar global market leader in innovative, Class III implantable hearing solutions.
Other assignments: Founding Board Member and President of the non-profit organization Joyful Life Cochlear Implant Fund (JLCIF)
Born: 1956
Education: Medical School, WVU, Residency (Anesthesia), Yale University, Fellowship, Yale University.
Main employment: Consultant in anesthesiology and Professor Emeritus at the Mayo Clinic College of Medicine.
Other assignments: Board member of the Anesthesia Patient Safety Foundation (APSF) and consultant to the US Food and Drug Administration (FDA).
Background: Founder of Acacia Designs B.V., which was acquired by Senzime AB in 2016. Head of Department at the University of Arkansas for Medical Sciences (UAMS) and Section Chief of the Department of Anesthesiology at Yale School of Medicine, and member of the Anesthesia Patient Safety Foundation.
Shareholding in Senzime: Sorin J. Brull owns a total of 3,770,309 shares in the company through the Pershing Trustee.